Dashboard
Analysis
Charting
Screener
Resources
Settings
NasdaqGS-MEDP
Mar '15
Dec '16
Sep '18
Jun '20
Mar '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
514.2
313.9
304.7
332.2
333.8
411.9
Total Shares Outstanding
28.2
28.1
29.8
30.6
31.1
31
Market Cap
14,483
8,815.9
9,090.8
10,176.5
10,375
12,768
Total Enterprise Value (TEV)
14,316.7
8,894.5
8,776
9,633.3
9,846.4
12,388.9
Buyback Yield
7.3%
12.9%
-0.4%
1.5%
-0.2%
-0.1%
Debt Paydown Yield
—
Shareholder Yield
P/S
6.1
4
4.2
4.8
5
6.3
P/Gross Profit
19.7
12.5
13.4
15.5
16.9
22.1
P/E
36
23.3
26.3
29.2
38.7
Earnings Yield
2.8%
4.3%
3.8%
3.4%
2.6%
P/OCF
20.4
14.4
15.6
16.7
18.1
23.7
P/FCF
21.4
15.2
16.8
17.8
19.4
25.4
FCF Yield
4.7%
6.6%
6%
5.6%
5.2%
3.9%
P/B
49.3
51.2
15.3
12.3
11.8
EV/Sales
4.1
4.6
EV/Gross Profit
19.5
12.6
12.9
14.7
16
EV/EBITDA
26.7
17.6
20.2
22.5
30.3
EV/EBIT
18.6
19.2
21.6
24.1
32.5
EV/OCF
20.1
14.5
15.1
15.8
17.1
22.9
EV/FCF
21.2
16.2
18.4
24.6
Margins
Gross Profit Margin
31.1%
31.6%
31.5%
29.7%
28.5%
Operating Margin
21.5%
21.4%
21.2%
19.7%
18.8%
EBITDA Margin
22.7%
22.5%
22.6%
21.1%
20.2%
Net Profit Margin
18.4%
18.7%
19.3%
19.2%
17.7%
16.7%
Effective Tax Rate
16.6%
15.6%
13.5%
15%
15.5%
14.4%
Pre-Tax Profit Margin
22%
22.2%
22.3%
20.9%
19.6%
Free Cash Flow Margin
28.7%
26%
25.1%
27.1%
25.9%
24.8%
OCF / Sales
30.2%
27.5%
27%
28.9%
27.7%
26.6%
OCF / Net Income
164.3%
146.8%
139.8%
150.6%
157.1%
158.9%
FCF / OCF
95.2%
94.4%
92.9%
94%
93.2%
93.1%
FCF / Net Income
156.3%
138.6%
129.9%
141.5%
146.5%
148%
FCF / EBITDA
126.4%
114.5%
111.4%
120.2%
122.4%
122.8%
Capital Efficiency
Return on Invested Capital
21.6%
21.7%
Return on Assets
21.9%
18.5%
18.2%
Return on Equity
77.4%
83.8%
58.7%
58.4%
50.8%
51.4%
Return on Total Capital
343.8%
320.3%
311.5%
282.3%
254.9%
237.7%
Return on Capital Employed
69.2%
70.9%
51.5%
51.7%
46.1%
46%
Return on Tangible Assets
35.2%
36.7%
32%
34.2%
31.2%
Receivables Turnover
7
6.6
7.3
7.1
6.8
Days Sales Outstanding
51.8
55.1
50.3
51.5
53.7
53.9
Payables Turnover
55
40.3
31.5
45.1
50.1
49
Days Payables Outstanding
9.1
11.6
8.1
7.5
Cash Conversion Cycle
45.2
46.1
43.4
46.5
46.4
Asset Turnover
1.2
1.1
Fixed Asset Turnover
9.3
8.6
8.4
8
7.8
Operating Cycle
CapEx to OCF
0
0.1
CapEx to Revenue
CapEx to Depreciation
1.4
1.3
Financial Health
Total Debt
119.1
124.9
126.7
126.2
128.3
131.8
Net Debt
-166.3
78.6
-314.8
-543.2
-528.6
-379.1
Current Ratio
0.6
0.4
0.7
0.9
1
Quick Ratio
0.5
0.3
0.8
Cash Ratio
0.2
Debt Ratio
Assets to Equity
6
3.2
2.5
2.4
Cash Flow to Debt Ratio
4.9
4.5
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-722.1
-878.5
-482.3
-246.1
-170
-283.9
Goodwill / Assets
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
-0.3
-0.6
-1.1
-1.2
-0.9
EBIT / Interest Expense
-17.9
EBITDA / Interest Expense
-19
(EBITDA - Capex) / Interest Expense
-17.6
Per Share
Revenue per Share
77.9
71.8
67.8
65.9
64.7
63.6
Basic EPS
13.8
13.5
13.1
11
Diluted EPS
14.3
11.4
10.6
Book Value per Share
9.7
5.5
18.7
25.8
27.5
23.9
Tangible Book Value per Share
-13.3
-16.9
-3.2
5.8
2.1
Cash per Share
9.4
1.5
13.9
20.9
20.5
Operating Cash Flow per Share
23.5
19.8
18.3
19
18
Free Cash Flow per Share
22.4
17
17.9
CapEx per Share
Weighted Avg. Shares Outstanding
29.5
30.2
30.8
30.9
Weighted Avg. Shares Outstanding Diluted
31.8
32
31.9
Common Size
SG&A to Revenue
8.4%
8.9%
9%
8.5%
8.6%
8.3%
Stock-based Comp to Revenue
1.8%
1.2%
0.9%
